Geptanolimab

(Synonyms: Genolimzumab; APL-501; CBT-501; GB-226)
Kundenbewertung

Based on 1 Customer Validation

Geptanolimab (CBT-501) is a humanized IgG4k monoclonal antibody against programmed death-1 (PD-1). Siplizumab inhibits the binding of PD-L1/L2 to PD-1 through a competitive action. Siplizumab can be used in research of cancer.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Reinheit: 97.72%
  • CAS. Nr.: 2348469-43-0
  • Molecular Weight:144.14 kDa
  • Speicherung:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biologische Aktivität
  • Chemical Information
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs
100 mg

Angebot einholen Auf Lager

Please select quantity
Amount: USD 0.00